Apr 5, 2024, 17:48
Katsuaki Maehara: Updated Oncology Drug List, Ver.2
Katsuaki Maehara, Director of Medical Education Colleagues, posted the following on X:
“Updated Oncology Drug List, Ver.2
Lung – NSCLC & Solid tumors
Oncogene-driven Target Therapies
– EGFR
– HER2 / HER3 / TROP2
– MET
– fusions
– Ras pathway
– Others
End…″
Source: Katsuaki Maehara/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33